Clinical Trial Update: A Study To Evaluate The Effect Of WELLBUTRIN XL On Intraocular Pressure [Phase 1]

View source ↗

Summary

Phase 1 study assessing whether WELLBUTRIN XL (bupropion extended-release) affects intraocular pressure in individuals with depressive disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Depressive Disorder

Drugs mentioned

• WELLBUTRIN XL (Bupropion hydrochloride)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Depressive Disorder | Phase 1 | Status: COMPLETED